ヒドロコルチゾンの世界市場レポート 2025年

ヒドロコルチゾン市場は、炎症性疾患や自己免疫疾患の有病率の増加により成長が見込まれています。これらの疾患は、免疫系が体内組織を攻撃し、慢性的な炎症や組織損傷を引き起こします。これらの疾患に対する治療法の採用が増加しているのは、有病率の増加と医療的治療法の進歩によるものです。ヒドロコルチゾンは、重度の喘息増悪やその他の炎症性疾患、自己免疫疾患において、炎症を抑え呼吸機能を迅速に改善するために利用され、緊急時に静脈内投与されることが多いです。例えば、2024年5月、米国国立保健統計センターのデータによると、米国における成人の喘息有病率は2021年の8.4％から2022年には8.7％に上昇し、同期間に喘息エピソードは3.3％から3.7％に増加しています。したがって、炎症性疾患や自己免疫疾患の有病率の増加は、ヒドロコルチゾン市場の成長を促進すると考えられます。

ヒドロコルチゾン市場の主要企業は、治療効果を高め、製品ラインナップを拡大するために、酪酸有効成分を含むローションなどの併用療法の開発に注力しています。ヒドロコルチゾンと酪酸ローションの併用は、抗炎症作用と酪酸の免疫調節作用の相乗効果を狙っており、皮膚状態の管理における皮膚バリア機能を改善する可能性があります。例えば、2023年11月、エストニアの製薬会社J.Molner AS.は、米国でヒドロコルチゾン酪酸ローション0.1%を発売し、世界展開戦略の重要な一歩を踏み出しました。この製品は炎症性皮膚疾患に対応するもので、国際市場でのプレゼンスを拡大するというモルナーのコミットメントを明確に示すものです。

2022年3月、米国を拠点とする非公開会社アドベントインターナショナル・コーポレーションは、医薬品セグメントにおける地域投資戦略の強化を目的として、メキシコとブラジルにおけるPerrigo Company plcの医薬品事業を買収しました。この買収により、アドベントは20年以上にわたる豊富な産業経験を活かし、同市場におけるポジションを強化します。アイルランドに本社を置くPerrigo Company plcは、ヒドロコルチゾンクリームを含む市販の健康ウェルネスソリューションに特化しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のヒドロコルチゾンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のヒドロコルチゾン市場：成長率分析
• 世界のヒドロコルチゾン市場の実績：規模と成長、2019～2024年
• 世界のヒドロコルチゾン市場の予測：規模と成長、2024～2029年、2034年
• 世界のヒドロコルチゾン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のヒドロコルチゾン市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• クリーム
• 注射
• 錠剤
• 世界のヒドロコルチゾン市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 非経口
• 経口
• 局所
• 世界のヒドロコルチゾン市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 副腎皮質機能障害
• アドレナリン症候群
• 高血中カルシウム
• 甲状腺炎
• 関節リウマチ
• 皮膚炎
• 喘息と慢性閉塞性肺疾患
• その他
• 世界のヒドロコルチゾン市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のヒドロコルチゾン市場、クリームのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所用ヒドロコルチゾンクリーム（0.5％、1％、2.5％）
• ヒドロコルチゾン軟膏
• 世界のヒドロコルチゾン市場、注射のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ヒドロコルチゾンコハク酸ナトリウム注射液
• ヒドロコルチゾン酢酸注射
• 世界のヒドロコルチゾン市場、錠剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口ヒドロコルチゾン錠（5mg、10mg、20mg）
• 徐放性ヒドロコルチゾン錠

第7章 地域別・国別分析

• 世界のヒドロコルチゾン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のヒドロコルチゾン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒドロコルチゾン市場：競合情勢
• ヒドロコルチゾン市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • Merck & Co Inc
  • AbbVie Inc.
  • Bayer AG

第31章 その他の大手企業と革新的企業

• Novartis AG
• The Dow Chemical Company
• GlaxoSmithKline plc（GSK）
• Viatris Inc.
• Solvay SA
• Teva Pharmaceutical Industries Ltd.
• Alcon Inc
• Sandoz International GmbH
• Valeant Pharmaceuticals International Inc
• Fresenius Kabi AG
• Macleods Pharmaceuticals Limited
• Sun Pharmaceutical Industries Ltd.
• Bausch & Lomb Incorporated
• Hikma Pharmaceuticals PLC
• Aspen Pharmacare Holdings Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• ヒドロコルチゾン市場、2029年：新たな機会を提供する国
• ヒドロコルチゾン市場、2029年：新たな機会を提供するセグメント
• ヒドロコルチゾン市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Hydrocortisone is a corticosteroid hormone naturally produced by the adrenal glands, essential for regulating metabolism and immune responses. It is synthesized and utilized in treating various conditions, primarily serving as an anti-inflammatory agent, commonly applied topically to alleviate skin inflammation and itching.

The principal forms of hydrocortisone include creams, injections, and tablets. Hydrocortisone cream is a topical medication applied directly to the skin to reduce inflammation, itching, and irritation caused by conditions such as eczema, dermatitis, and insect bites. These products are administered via different routes including parenteral, oral, and topical methods, addressing conditions such as adrenocortical dysfunction, adrenergic syndrome, hypercalcemia, thyroiditis, rheumatoid arthritis, dermatitis, asthma, chronic obstructive pulmonary disease (COPD), among others. Distribution channels for hydrocortisone products encompass hospital pharmacies, retail pharmacies, and online platforms.

The hydrocortisone market research report is one of a series of new reports from the business research company that provides hydrocortisone market statistics, including hydrocortisone industry global market size, regional shares, competitors with an hydrocortisone market share, detailed hydrocortisone market segments, market trends and opportunities, and any further data you may need to thrive in the hydrocortisone industry. This hydrocortisone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hydrocortisone market size has grown strongly in recent years. It will grow from $1.52 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising skin disorder prevalence, an aging population, increased awareness and accessibility, pharmaceutical industry growth, and emerging market expansion.

The hydrocortisone market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to technological advancements, OTC demand surge, research and demand investments, growing disposable income, expanded distribution channels. Major trends in the forecast period include natural ingredient focus, combination therapies, personalized treatments, hydrocortisone-infused products, and sustainability emphasis.

The hydrocortisone market is expected to grow due to the increasing prevalence of inflammatory and autoimmune diseases. These conditions involve the immune system attacking the body's tissues, leading to chronic inflammation and tissue damage. The rising adoption of treatments for these diseases is driven by their growing prevalence and advancements in medical therapies. Hydrocortisone is utilized in severe asthma exacerbations and other inflammatory and autoimmune diseases to reduce inflammation and improve respiratory function quickly, often administered intravenously in emergency situations. For example, in May 2024, data from the National Center for Health Statistics indicated a rise in asthma prevalence among adults in the United States from 8.4% in 2021 to 8.7% in 2022, with an increase in asthma episodes from 3.3% to 3.7% over the same period. Therefore, the increasing prevalence of inflammatory and autoimmune diseases will drive the growth of the hydrocortisone market.

Leading companies in the hydrocortisone market are focusing on developing combination therapies, such as lotions containing butyrate active ingredients, to enhance treatment effectiveness and expand their product offerings. Hydrocortisone combined with butyrate lotion aims to synergize anti-inflammatory properties with butyrate's immunomodulatory effects, potentially improving skin barrier function in managing skin conditions. For instance, in November 2023, J. Molner AS., an Estonian pharmaceutical firm, launched Hydrocortisone Butyrate Lotion, 0.1%, in the United States, marking a significant step in its strategy to expand globally. This product addresses inflammatory skin conditions, underscoring Molner's commitment to broadening its international market presence.

In March 2022, Advent International Corporation, a US-based private equity firm, acquired Perrigo Company plc's pharmaceutical businesses in Mexico and Brazil, aiming to bolster its regional investment strategy in the pharmaceutical sector. This acquisition strengthens Advent's position in the market, leveraging its extensive industry experience spanning more than two decades. Perrigo Company plc, based in Ireland, specializes in over-the-counter health and wellness solutions, including hydrocortisone creams.

Major companies operating in the hydrocortisone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc, AbbVie Inc., Bayer AG, Novartis AG, The Dow Chemical Company, GlaxoSmithKline plc (GSK), Viatris Inc., Solvay SA, Teva Pharmaceutical Industries Ltd., Alcon Inc, Sandoz International GmbH, Valeant Pharmaceuticals International Inc, Fresenius Kabi AG, Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Ivax Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited, Impax Laboratories LLC, Akorn Incorporated, Taro Pharmaceutical Industries Ltd, Lannett Company Inc, Salix Pharmaceuticals Inc

North America was the largest region in the hydrocortisone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hydrocortisone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hydrocortisone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hydrocortisone market consists of sales of hydrocortisone creams, ointments, lotions, and oral formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hydrocortisone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hydrocortisone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hydrocortisone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hydrocortisone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Cream; Injection; Tablet
• 2) By Route Of Administration: Parenteral; Oral; Topical
• 3) By Application: Adrenocortical Dysfunction; Adrenergic Syndrome; High Blood Calcium; Thyroiditis; Rheumatoid Arthritis; Dermatitis; Asthma And Chronic Obstructive Pulmonary Disease; Other Application
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Cream: Topical Hydrocortisone Cream (0.5%, 1%, 2.5%); Hydrocortisone Ointment
• 2) By Injection: Hydrocortisone Sodium Succinate Injection; Hydrocortisone Acetate Injection
• 3) By Tablet: Oral Hydrocortisone Tablets (5mg, 10mg, 20mg); Extended-Release Hydrocortisone Tablets
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co Inc; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hydrocortisone Market Characteristics

3. Hydrocortisone Market Trends And Strategies

4. Hydrocortisone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hydrocortisone Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hydrocortisone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hydrocortisone Market Growth Rate Analysis
• 5.4. Global Hydrocortisone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hydrocortisone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hydrocortisone Total Addressable Market (TAM)

6. Hydrocortisone Market Segmentation

• 6.1. Global Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cream
• Injection
• Tablet
• 6.2. Global Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Oral
• Topical
• 6.3. Global Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adrenocortical Dysfunction
• Adrenergic Syndrome
• High Blood Calcium
• Thyroiditis
• Rheumatoid Arthritis
• Dermatitis
• Asthma And Chronic Obstructive Pulmonary Disease
• Other Application
• 6.4. Global Hydrocortisone Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Hydrocortisone Market, Sub-Segmentation Of Cream, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Hydrocortisone Cream (0.5%, 1%, 2.5%)
• Hydrocortisone Ointment
• 6.6. Global Hydrocortisone Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrocortisone Sodium Succinate Injection
• Hydrocortisone Acetate Injection
• 6.7. Global Hydrocortisone Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Hydrocortisone Tablets (5mg, 10mg, 20mg)
• Extended-Release Hydrocortisone Tablets

7. Hydrocortisone Market Regional And Country Analysis

• 7.1. Global Hydrocortisone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hydrocortisone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hydrocortisone Market

• 8.1. Asia-Pacific Hydrocortisone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hydrocortisone Market

• 9.1. China Hydrocortisone Market Overview
• 9.2. China Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hydrocortisone Market

• 10.1. India Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hydrocortisone Market

• 11.1. Japan Hydrocortisone Market Overview
• 11.2. Japan Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hydrocortisone Market

• 12.1. Australia Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hydrocortisone Market

• 13.1. Indonesia Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hydrocortisone Market

• 14.1. South Korea Hydrocortisone Market Overview
• 14.2. South Korea Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hydrocortisone Market

• 15.1. Western Europe Hydrocortisone Market Overview
• 15.2. Western Europe Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hydrocortisone Market

• 16.1. UK Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hydrocortisone Market

• 17.1. Germany Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hydrocortisone Market

• 18.1. France Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hydrocortisone Market

• 19.1. Italy Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hydrocortisone Market

• 20.1. Spain Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hydrocortisone Market

• 21.1. Eastern Europe Hydrocortisone Market Overview
• 21.2. Eastern Europe Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hydrocortisone Market

• 22.1. Russia Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hydrocortisone Market

• 23.1. North America Hydrocortisone Market Overview
• 23.2. North America Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hydrocortisone Market

• 24.1. USA Hydrocortisone Market Overview
• 24.2. USA Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hydrocortisone Market

• 25.1. Canada Hydrocortisone Market Overview
• 25.2. Canada Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hydrocortisone Market

• 26.1. South America Hydrocortisone Market Overview
• 26.2. South America Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hydrocortisone Market

• 27.1. Brazil Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hydrocortisone Market

• 28.1. Middle East Hydrocortisone Market Overview
• 28.2. Middle East Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hydrocortisone Market

• 29.1. Africa Hydrocortisone Market Overview
• 29.2. Africa Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hydrocortisone Market Competitive Landscape And Company Profiles

• 30.1. Hydrocortisone Market Competitive Landscape
• 30.2. Hydrocortisone Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Hydrocortisone Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. The Dow Chemical Company
• 31.3. GlaxoSmithKline plc (GSK)
• 31.4. Viatris Inc.
• 31.5. Solvay SA
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Alcon Inc
• 31.8. Sandoz International GmbH
• 31.9. Valeant Pharmaceuticals International Inc
• 31.10. Fresenius Kabi AG
• 31.11. Macleods Pharmaceuticals Limited
• 31.12. Sun Pharmaceutical Industries Ltd.
• 31.13. Bausch & Lomb Incorporated
• 31.14. Hikma Pharmaceuticals PLC
• 31.15. Aspen Pharmacare Holdings Limited

32. Global Hydrocortisone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hydrocortisone Market

34. Recent Developments In The Hydrocortisone Market

35. Hydrocortisone Market High Potential Countries, Segments and Strategies

• 35.1 Hydrocortisone Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hydrocortisone Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hydrocortisone Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer